Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 24948 | 247 | 27.7 | 68% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | CLORICROMENE | Author keyword | 53 | 89% | 10% | 24 |
| 2 | LIPIDIC AMINO ACID | Author keyword | 23 | 100% | 4% | 10 |
| 3 | LIPOAMINO ACIDS | Author keyword | 21 | 54% | 11% | 27 |
| 4 | LIPIDIC PEPTIDE | Author keyword | 15 | 77% | 4% | 10 |
| 5 | LIPIDIC ALPHA AMINO ACIDS | Author keyword | 6 | 100% | 2% | 4 |
| 6 | SPLANCHNIC ARTERY OCCLUSION SHOCK | Author keyword | 6 | 50% | 3% | 8 |
| 7 | CIPDD | Address | 4 | 75% | 1% | 3 |
| 8 | CEM MTX CELLS | Author keyword | 3 | 100% | 1% | 3 |
| 9 | CHARGED LIPOSACCHARIDE | Author keyword | 3 | 100% | 1% | 3 |
| 10 | TRANSMEMBRANE DRUG DELIVERY | Author keyword | 3 | 100% | 1% | 3 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | CLORICROMENE | 53 | 89% | 10% | 24 | Search CLORICROMENE | Search CLORICROMENE |
| 2 | LIPIDIC AMINO ACID | 23 | 100% | 4% | 10 | Search LIPIDIC+AMINO+ACID | Search LIPIDIC+AMINO+ACID |
| 3 | LIPOAMINO ACIDS | 21 | 54% | 11% | 27 | Search LIPOAMINO+ACIDS | Search LIPOAMINO+ACIDS |
| 4 | LIPIDIC PEPTIDE | 15 | 77% | 4% | 10 | Search LIPIDIC+PEPTIDE | Search LIPIDIC+PEPTIDE |
| 5 | LIPIDIC ALPHA AMINO ACIDS | 6 | 100% | 2% | 4 | Search LIPIDIC+ALPHA+AMINO+ACIDS | Search LIPIDIC+ALPHA+AMINO+ACIDS |
| 6 | SPLANCHNIC ARTERY OCCLUSION SHOCK | 6 | 50% | 3% | 8 | Search SPLANCHNIC+ARTERY+OCCLUSION+SHOCK | Search SPLANCHNIC+ARTERY+OCCLUSION+SHOCK |
| 7 | CEM MTX CELLS | 3 | 100% | 1% | 3 | Search CEM+MTX+CELLS | Search CEM+MTX+CELLS |
| 8 | CHARGED LIPOSACCHARIDE | 3 | 100% | 1% | 3 | Search CHARGED+LIPOSACCHARIDE | Search CHARGED+LIPOSACCHARIDE |
| 9 | TRANSMEMBRANE DRUG DELIVERY | 3 | 100% | 1% | 3 | Search TRANSMEMBRANE+DRUG+DELIVERY | Search TRANSMEMBRANE+DRUG+DELIVERY |
| 10 | AMINO ACIDS FATTY | 2 | 67% | 1% | 2 | Search AMINO+ACIDS++FATTY | Search AMINO+ACIDS++FATTY |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | AD6 8 MONOCHLORO 3 BETA DIETHYLAMINOETHYL 4 METHYL 7 ETHOXYCARBONYLMETHOXY COUMA | 21 | 90% | 4% | 9 |
| 2 | AD6 | 17 | 79% | 4% | 11 |
| 3 | CLORICROMENE | 9 | 64% | 4% | 9 |
| 4 | LIPOAMINO ACID | 6 | 58% | 3% | 7 |
| 5 | LIPIDIC AMINO ACIDS | 3 | 39% | 3% | 7 |
| 6 | LIPOAMINO ACIDS | 3 | 39% | 3% | 7 |
| 7 | ALKYLAMINO ACIDS | 3 | 60% | 1% | 3 |
| 8 | INCREASED LIPOPHILIC CHARACTER | 2 | 67% | 1% | 2 |
| 9 | CARBOHYDRATE MODIFIED ENKEPHALINS | 2 | 50% | 1% | 3 |
| 10 | LIPIDIC PEPTIDES | 2 | 50% | 1% | 3 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| A NOVEL CHEMICAL APPROACH TO DRUG-DELIVERY - LIPIDIC AMINO-ACID CONJUGATES | 1994 | 80 | 27 | 41% |
| Lipoamino Acid Prodrugs of Paclitaxel: Synthesis and Cytotoxicity Evaluation on Human Anaplastic Thyroid Carcinoma Cells | 2009 | 9 | 67 | 12% |
| CLORICROMENE | 1991 | 5 | 22 | 73% |
| Synthesis and use of N,N-di-Boc-glutamate gamma-semialdehydes and related aldehydes | 2003 | 2 | 44 | 39% |
| Lipid, sugar and liposaccharide based delivery systems | 2001 | 76 | 83 | 11% |
| Peptides As Therapeutics with Enhanced Bioactivity | 2012 | 21 | 140 | 9% |
| Synthesis of optically active lipidic alpha-amino acids and lipidic 2-amino alcohols | 1999 | 8 | 28 | 25% |
| Lipoamino Acids as Major Components of Absorption Promoters in Drug Delivery | 2012 | 6 | 141 | 16% |
| Lipid, sugar and liposaccharide based delivery systems 2 | 2004 | 29 | 37 | 11% |
| ENDOTHELIUM AS A THERAPEUTIC TARGET IN PERIPHERAL OCCLUSIVE ARTERIAL DISEASES - CONSIDERATION FOR PHARMACOLOGICAL INTERVENTIONS | 1994 | 3 | 83 | 14% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | CIPDD | 4 | 75% | 1.2% | 3 |
| 2 | CATTEDRA PATOL GEN 3 | 1 | 100% | 0.8% | 2 |
| 3 | SEZ TECNOL FARMACEUT | 1 | 33% | 0.8% | 2 |
| 4 | SECT PHARMACEUT TECHNOL | 1 | 25% | 0.8% | 2 |
| 5 | MED CHEM PATHOBIOCHEM MOL BIOL | 0 | 33% | 0.4% | 1 |
| 6 | SCMB | 0 | 13% | 1.2% | 3 |
| 7 | DIPARTIMENTO BIOTECNOL MED MED TRASLAZIONALE | 0 | 20% | 0.4% | 1 |
| 8 | VET GEN PATHOL PATHOL ANAT | 0 | 20% | 0.4% | 1 |
| 9 | ETNALEAD SRL | 0 | 14% | 0.4% | 1 |
| 10 | IND PHARMACEUT | 0 | 14% | 0.4% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000114060 | AK TUMORIMMUNOL VAKZINE//MALP 2//N ELECTROPHILIC AMINATION |
| 2 | 0.0000069194 | LIPID NANOCAPSULES//U1066//U646 |
| 3 | 0.0000068696 | NORZOANTHAMINE//MAKOMOTAKE//ZOANTHAMINE |
| 4 | 0.0000062936 | ALPHA BETA POLYN 2 HYDROXYETHYL DL ASPARTAMIDE//POLYSUCCINIMIDE//DIPARTIMENTO CHIM TECNOL FARMACEUT |
| 5 | 0.0000056648 | IDEBENONE//SOLANESOL//BLANC CHLOROMETHYLATION REACTION |
| 6 | 0.0000056304 | SODIUM CAPRATE//SUPPOSITORY//ABSORPTION ENHANCER |
| 7 | 0.0000050151 | PROSTATIC ARTERY EMBOLIZATION//UNIV ANAT//PROSTATIC ARTERIAL EMBOLIZATION |
| 8 | 0.0000046002 | PEPTIDE PROT CHEM//PHYSICOCHEM UNIT//QUIM PEPTIDS PROT |
| 9 | 0.0000045746 | 2 SEC BUTYLPHENYL METHYLCARBAMATE BPMC//CENTRAL CHOLINERGIC SYSTEMS//CHOLINERGIC HYPERTENSION |
| 10 | 0.0000044784 | DIFFUSION CELL EXPERIMENTS//TRANSFORMED POTTS GUY EQUATION//ROBERTS SLOAN EQUATION |